Tevis Investment Management Becton Dickinson & CO Transaction History

Tevis Investment Management

$134 Million
Q3 2024

A detailed history of Tevis Investment Management transactions in Becton Dickinson & CO stock. As of the latest transaction made, Tevis Investment Management holds 1,567 shares of BDX stock, worth $355,630. This represents 0.28% of its overall portfolio holdings.

Number of Shares

1,567

Previous 1,567 -0.0%

Holding current value

$355,630

Previous $366,000 3.01%

% of portfolio

0.28%

Previous 0.3%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$225.07 - $246.17 $16,430 - $17,970	-73 Reduced 4.45%	1,567 $366,000
Q1 2024 Apr 16, 2024	SELL	$233.45 - $247.73 $4,202 - $4,459	-18 Reduced 1.09%	1,640 $405,000
Q4 2023 Jan 19, 2024	SELL	$232.24 - $267.23 $2,090 - $2,405	-9 Reduced 0.54%	1,658 $404,000
Q3 2023 Oct 16, 2023	SELL	$254.9 - $283.59 $185,567 - $206,453	-728 Reduced 30.4%	1,667 $430,000
Q2 2023 Aug 01, 2023	BUY	$238.39 - $265.32 $2,622 - $2,918	11 Added 0.46%	2,395 $632,000
Q1 2023 May 02, 2023	SELL	$229.71 - $259.35 $15,620 - $17,635	-68 Reduced 2.77%	2,384 $590,000
Q4 2022 Jan 30, 2023	BUY	$218.29 - $256.91 $33,834 - $39,821	155 Added 6.75%	2,452 $623,000
Q3 2022 Nov 07, 2022	BUY	$51.03 - $264.23 $1,173 - $6,077	23 Added 1.01%	2,297 $512,000
Q2 2022 Aug 08, 2022	BUY	$234.74 - $275.42 $31,924 - $37,457	136 Added 6.36%	2,274 $560,000
Q1 2022 Aug 05, 2022	SELL	$243.64 - $270.48 $3,167 - $3,516	-13 Reduced 0.6%	2,138 $570,000
Q4 2021 Aug 05, 2022	BUY	$230.08 - $250.94 $494,902 - $539,771	2,151 New	2,151 $554,000

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tevis Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Tevis Investment Management with notifications on news.

Account

Tevis Investment Management Becton Dickinson & CO Transaction History